# Amgen Inc. (AMGN) — Q4-2009 Earnings Results

**Report date:** 2010-01-25 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2009

## Post-Earnings Brief

### Headline

Amgen Misses on EPS, Stock Down 1.57%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.05 | N/A | -5.66% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Overall, management expressed concerns about market conditions impacting performance. They are prioritizing cost control measures.

**Key quotes:**

> Management noted challenges in the current market environment.

> They emphasized a focus on cost management and operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report indicates some struggles, particularly reflected in the EPS miss. The stock's decline of 1.57% suggests investor concern over the company's current performance and market challenges. Without guidance, investors may remain cautious about future prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2009_